Delivery Order SPE2DB24D9803-SPE2DB25FJSJB
- Not listed
- The Defense Logistics Agency awarded a $6,701.70 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for NovoLog 100 Unit/mL FlexPen 3mL insulin pens, with an ultimate completion date of July 23, 2025. This delivery order was issued without a set-aside designation and is being performed at the vendor's location in Park Ridge, Illinois. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, was selected to fulfill this requirement through its...
- This federal contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $2,265.00 firm fixed-price delivery order is for the supply of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a type of insulin medication. The contract has a period of performance through June 25, 2025 and was awarded on June 24, 2025. DMS Pharmaceutical Group Inc. has a significant single-award Indefinite...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order for $2,004.99 under an indefinite delivery contract with the Defense Logistics Agency to supply Novolog 100 unit/ml Flexpen 3ml insulin injections. The delivery order is for fulfillment to Defense Logistics Agency Troop Support Medical facilities located in Park Ridge, Illinois, with performance to be completed by November 2, 2023. DMS Pharmaceutical Group holds additional delivery orders and an IDV through December...
- The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract valued at $1,650.63 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of insulin glargine-yfgn U100 pen 3mL to support the medical supply needs of military health facilities. This delivery order is issued under DMS Pharmaceutical Group's existing indefinite delivery vehicle (IDV) contract SPE2DB24D2106 with DLA, which has a ceiling...
- The Defense Logistics Agency Troop Support Medical has awarded a firm fixed price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide NOVOLOG 100 UNIT/ML FLEXPEN 3ML. The contract has a potential value of $1,891.50 and a completion date of January 17, 2024. DMS Pharmaceutical Group Inc. is a leading pharmaceutical wholesaler that provides a range of brand and generic pharmaceutical and medical supplies to the federal government, particularly the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $6,177.60 firm fixed-price delivery order is for NOVOLOG 100 UNIT/ML FLEXPEN 3ML medical supplies. The award is not associated with a set-aside program. DMS Pharmaceutical Group holds a significant $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which...
- The U.S. government's Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract, SPE2DX15D9249|SPE2DX24FTMGE, valued at $1,319.60 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This order is for the supply of Lantus Solostar 100 unit/mL 3mL insulin pens and is not set aside for any specific business category. DMS Pharmaceutical Group holds a larger indefinite delivery contract, 4600082013 under the...
- The Defense Logistics Agency Troop Support Medical awarded DMS Pharmaceutical Group Inc. a firm fixed price delivery order for $19,500 to provide 8503345228, which is human insulin. DMS Pharmaceutical Group Inc. will deliver the product to Park Ridge, Illinois by July 5, 2016. DMS Pharmaceutical Group Inc. is a woman-owned small business and woman-owned business pharmaceutical wholesaler that holds numerous contracts with the Defense Logistics Agency to supply pharmaceutical and medical products...
- This federal contract award is a delivery order from the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The award, valued at $2,017.60, is for the supply of NOVOLOG 100 UNIT/ML VIAL 10ML, a pharmaceutical product. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program. The...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $18,488.12 by the Defense Logistics Agency's Medical Supply Chain division on July 24, 2025. This delivery order, which carries an ultimate completion date of July 30, 2025, represents a discrete purchase order issued under the company's larger Indefinite Delivery Contract with the Defense Logistics Agency valued at $499.9...
- SPE2DB24D9803Indefinite Delivery Contract
- SPE2DB24D9803-SPE2DB25FJSJBDelivery Order
The Defense Logistics Agency issued a firm fixed-price delivery order valued at $11,660.20 to DMS Pharmaceutical Group Inc. for the supply of Novolog 100 Unit/mL FlexPen 3mL insulin pens. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded this delivery order without a set-aside designation on July 31, 2025, with an ultimate completion date of August 1, 2025. The pharmaceutical product will be delivered to Park Ridge, Illinois and represents a specific fulfillment under the company's broader pharmaceutical supply contract with DLA. This delivery order is issued under DMS Pharmaceutical Group's substantial Indefinite Delivery Contract with the Defense Logistics Agency valued at $499.9 million and extending through November 2026. The IDC enables DLA to procure a comprehensive range of pharmaceutical products, including prescription medications, biologics, and medical consumables, to support the medical supply needs of Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain through consistent performance on delivery orders covering diverse product categories from specialty medications to injectable treatments, leveraging its woman-owned small business status to compete effectively in federal procurement markets.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.7k | 7/31/25 |